First-Line Antibiotics for Nosocomial Neonatal Infections

Introduction to Nosocomial Infections

The World Health Organization recommends amikacin plus cloxacillin as the first-line empiric therapy for nosocomial infections in newborns, with vancomycin plus ceftazidime as an alternative when methicillin-resistant staphylococci or resistant gram-negative bacteria are suspected 1, 2

Nosocomial infections have distinctly different microbiology compared to early-onset sepsis, requiring different antibiotic coverage 4
The American Academy of Pediatrics and other guideline societies note that early-onset pathogens include Group B Streptococcus, E. coli, and Listeria monocytogenes, whereas nosocomial pathogens include coagulase-negative staphylococci, Staphylococcus aureus (including MRSA), gram-negative bacteria, and enterococci 4, 5

The World Health Organization designates amikacin plus cloxacillin as the primary first-line option for nosocomial sepsis, providing coverage against resistant staphylococci and gram-negative bacteria 1, 2
Vancomycin should replace cloxacillin when there is concern for methicillin-resistant organisms, particularly in infants with central venous catheters or prolonged NICU stays 4

Initiate antibiotics within 1 hour for newborns with septic shock, and within 3 hours for sepsis without shock 6, 5
Obtain blood cultures before antibiotic administration, but never delay treatment waiting for results 5

The initial empiric choice must be modified by knowledge of local bacterial epidemiology and resistance patterns 1, 4
Amikacin demonstrates better sensitivity than gentamicin in many nosocomial settings, and imipenem shows the lowest resistance rates but should be reserved for documented resistant infections 1, 4

Delaying antibiotic escalation: if no clinical improvement occurs after 48-72 hours, broaden coverage immediately 6
Ignoring local antibiograms: resistance patterns vary significantly between institutions and must guide empiric selection 1, 4
Failing to narrow therapy: once culture results return, de-escalate to the narrowest effective spectrum 6
Continuing antibiotics unnecessarily: discontinue after 48 hours if cultures are negative and clinical probability of sepsis is low 6, 5